Cytopoint vs. Immunotherapy for Dogs: Long-Term Allergy Management Compared

By Emiel Maddens  ·  Reviewed in consultation with licensed veterinary professionals  ·  Updated April 2026  ·  11 min read

Photo by Mikhail Nilov on Pexels

For dogs with atopic dermatitis, the question is rarely whether to treat, but rather how to treat for the best long-term outcome. Two of the most discussed options in veterinary dermatology are Cytopoint (lokivetmab), a monoclonal antibody injection that provides rapid itch relief, and allergen-specific immunotherapy (ASIT), a customized desensitization program that aims to retrain the immune system. Both are legitimate, evidence-based approaches, but they work in fundamentally different ways and serve different goals.

This guide provides an honest comparison of both treatments, examining their mechanisms, efficacy, cost considerations, timelines, and ideal use cases. By the end, you will have the information needed to have a productive conversation with your veterinarian about which approach, or combination of approaches, best fits your dog's needs.

What Are Cytopoint and Immunotherapy?

Understanding how each treatment works at a biological level explains why their effects, timelines, and roles in allergy management differ so significantly.

Cytopoint (Lokivetmab)

Cytopoint is a caninized monoclonal antibody that specifically targets and neutralizes interleukin-31 (IL-31), a key cytokine involved in triggering the itch sensation in allergic dogs. Administered as a subcutaneous injection by a veterinarian, it begins working within 24 hours and provides itch relief lasting 4 to 8 weeks in most dogs. Because it targets a single molecule in the itch pathway, it does not broadly suppress the immune system.

Allergen-Specific Immunotherapy (ASIT)

Immunotherapy involves administering gradually increasing doses of the specific allergens to which a dog has tested positive, with the goal of inducing immune tolerance. The allergen extract is custom-formulated based on intradermal or serum allergy test results and can be delivered via subcutaneous injections or sublingual (under-the-tongue) drops. The process typically takes 6 to 12 months to reach full efficacy.

Symptom Control vs. Disease Modification

This is the fundamental distinction. Cytopoint controls symptoms by blocking the itch signal. When the injection wears off, the itch returns because the underlying immune dysfunction has not changed. Immunotherapy modifies the disease itself by shifting the immune response from allergic inflammation toward tolerance. Successfully treated dogs may need less medication over time.

Combination Approach

Many veterinary dermatologists use both treatments simultaneously. Cytopoint provides immediate comfort while immunotherapy slowly builds tolerance in the background. As immunotherapy takes effect, some dogs require Cytopoint injections less frequently or at lower doses.

Allergen-specific immunotherapy uses customized allergen extracts to gradually retrain the immune system over months to years.

Photo by Tima Miroshnichenko on Pexels

How Do Cytopoint and Immunotherapy Work?

Understanding the immunological mechanisms behind each treatment explains why one provides rapid symptom control while the other offers the possibility of lasting disease modification.

1. IL-31 and the Itch Pathway

IL-31 is produced by activated T-helper cells in allergic dogs and binds to receptors on sensory neurons, directly triggering the sensation of itch. Cytopoint works by binding IL-31 before it reaches these nerve receptors, effectively blocking the signal.

2. Immune Dysregulation in Atopy

Atopic dermatitis involves a shift toward Th2-dominant immune responses, with excessive production of IgE antibodies and pro-inflammatory cytokines. Immunotherapy aims to shift this balance back toward Th1/regulatory T-cell responses, promoting tolerance.

3. Allergen Sensitization

Dogs become sensitized to environmental allergens through skin exposure (facilitated by barrier defects) and possibly respiratory exposure. Once sensitized, re-exposure triggers the inflammatory cascade that immunotherapy seeks to reverse.

4. Genetic Factors

The predisposition to develop atopic dermatitis is inherited, involving genes that control skin barrier function and immune regulation. Neither Cytopoint nor immunotherapy changes the genetic predisposition, but immunotherapy can modify how the immune system responds to allergens within that genetic framework.

Which Breeds Are Most Affected?

Breeds most commonly affected by atopic dermatitis are the most frequent candidates for both Cytopoint and immunotherapy, either alone or in combination.

• Labrador Retriever: Labrador Retrievers are frequently prescribed both Cytopoint and immunotherapy due to their high incidence of atopic dermatitis and excellent compliance with long-term treatment programs.
• Golden Retriever: Golden Retrievers respond well to both treatment modalities, though their tendency toward severe atopy often means combination therapy produces the best quality of life.
• French Bulldog: French Bulldogs' severe allergic predisposition and skin fold complications make them common candidates for combined Cytopoint and immunotherapy, often alongside topical skin fold management.
• West Highland White Terrier: Westies are among the most challenging atopic patients and frequently require multimodal therapy including both Cytopoint for itch control and immunotherapy for long-term disease modification.
• Boxer: Boxers develop atopic dermatitis frequently and tend to respond well to immunotherapy, making them good candidates for the combined approach during the induction period.

Signs and Symptoms

Comparing the clinical experience of each treatment helps set realistic expectations and guides decision-making around timing, lifestyle, and goals.

Onset of Itch Relief

Cytopoint typically provides noticeable itch reduction within 24 hours of injection, with maximum effect by day 3. Immunotherapy does not provide immediate itch relief and may take 3 to 6 months before any improvement is noticed.

Duration of Effect

Each Cytopoint injection lasts 4 to 8 weeks, with some dogs experiencing shorter or longer durations. Immunotherapy, once effective, provides continuous protection as long as maintenance doses are administered.

Consistency of Response

Cytopoint response tends to be predictable and consistent from one injection to the next in a given dog. Immunotherapy response can be variable, with some dogs experiencing excellent improvement and others showing minimal change.

Seasonal Variation

Dogs on Cytopoint may need more frequent injections during high-pollen seasons. Dogs successfully treated with immunotherapy often handle seasonal allergen spikes better because their immune tolerance extends across exposure levels.

Breakthrough Itching

Some dogs on Cytopoint experience itch breakthroughs before the next scheduled injection, particularly toward the end of the dosing interval. Immunotherapy patients may have occasional flares but tend to have a higher baseline of comfort once tolerance is established.

Side Effect Profile

Cytopoint has an exceptionally clean safety profile with no significant reported side effects in clinical trials. Immunotherapy carries a small risk of localized injection-site reactions and extremely rare anaphylactic reactions, though serious adverse events are uncommon.

Diagnosis

The diagnostic requirements differ between the two treatments. Immunotherapy requires allergy testing to create a custom formulation, while Cytopoint can be started without testing.

Clinical Diagnosis of Atopy

Before either treatment is considered, atopic dermatitis must be diagnosed based on clinical criteria (Favrot criteria), ruling out other causes of pruritus such as parasites, infections, and food allergy through systematic evaluation.

Intradermal Testing for Immunotherapy

Intradermal skin testing is the preferred method for identifying specific allergens to include in immunotherapy formulations. Tiny amounts of common allergens are injected into the skin, and reactions are graded to build a custom treatment serum.

Serum IgE Testing

Blood-based allergen testing measures circulating IgE antibodies against environmental allergens. While less precise than intradermal testing, it is more widely available and can be used to formulate immunotherapy when intradermal testing is not accessible.

No Testing Required for Cytopoint

Cytopoint does not require allergy testing because it blocks the itch pathway regardless of which specific allergens are triggering the response. This makes it an accessible option even when allergy testing is not available or affordable.

Elimination Diet to Rule Out Food Allergy

Before committing to either treatment, food allergy should be ruled out with an elimination diet trial, as neither Cytopoint nor immunotherapy effectively treats food-allergic disease.

Treatment

Both treatments are administered differently, involve different time commitments, and require different levels of owner involvement in the management process.

Cytopoint Administration

Cytopoint is administered as a single subcutaneous injection at the veterinary clinic every 4 to 8 weeks. Dosing is weight-based, and no blood work or monitoring is required. The injection itself is well-tolerated with minimal discomfort.

Subcutaneous Immunotherapy (SCIT)

Traditional immunotherapy involves subcutaneous injections given at home by the owner. The induction phase involves gradually increasing doses over several weeks, followed by a maintenance phase of injections every 2 to 4 weeks, potentially for life.

Sublingual Immunotherapy (SLIT)

Sublingual drops are an alternative to injections for immunotherapy delivery. The allergen extract is applied under the tongue twice daily using a pump spray. Many owners prefer this method due to its ease and avoidance of needles.

Cost Comparison

Cytopoint costs approximately $50 to $150 per injection depending on dog size, totaling $600 to $1,800 annually for monthly injections. Immunotherapy involves higher upfront costs for allergy testing ($200-$500) and serum formulation ($200-$400), but annual maintenance costs of $300 to $600 are often lower than ongoing Cytopoint.

Combining Treatments

During the 6-to-12-month immunotherapy induction period, Cytopoint injections keep the dog comfortable. As immunotherapy takes effect, the veterinarian may gradually extend the interval between Cytopoint injections to assess how much natural tolerance has developed.

Monitoring and Adjustments

Cytopoint requires minimal monitoring beyond assessing itch levels before each injection. Immunotherapy requires periodic reassessment of allergen panels and may need dose or formulation adjustments based on clinical response.

Prevention

Maximizing treatment effectiveness for either approach involves complementary strategies that address the skin barrier and allergen exposure.

Early Intervention with Immunotherapy

Starting immunotherapy early in the course of atopic dermatitis, before chronic skin changes develop, is associated with better outcomes. Younger dogs tend to respond more favorably than older dogs with longstanding disease.

Consistent Cytopoint Scheduling

Maintaining regular Cytopoint injection intervals prevents breakthrough itching and the skin damage that comes from scratching. Gaps in treatment can allow flares that take longer to bring back under control.

Environmental Allergen Reduction

Regardless of which treatment is used, reducing allergen exposure through air purifiers, frequent bedding washing, paw wiping after outdoor walks, and maintaining low indoor humidity complements both approaches.

Skin Barrier Support

Ceramide-containing topical products and omega-3 fatty acid supplementation help restore the skin barrier, reducing allergen penetration and potentially enhancing the effectiveness of both Cytopoint and immunotherapy.

Regular Dermatology Follow-Up

Annual or biannual visits with a veterinary dermatologist allow for treatment optimization, identification of new allergen sensitivities, and adjustment of immunotherapy formulations as needed.

Related Symptoms

Dogs with this condition often show these symptoms. Our guides explain each one:

• How to Relieve Your Dog's Itchy Skin, Both Cytopoint and immunotherapy target itch, but through completely different mechanisms.
• Why Your Dog Is Scratching but Has No Fleas, Persistent scratching despite flea prevention often points to atopic dermatitis requiring advanced treatment.
• Complete Guide to Dog Skin Allergies, Understanding the full spectrum of allergy treatments helps you make informed decisions about Cytopoint vs. immunotherapy.

FAQs: Cytopoint vs. Immunotherapy for Dogs

Q: q

a

Q: q

a

Q: q

a

Q: q

a

Sources

Michels, G.M. et al. A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis. Veterinary Dermatology, 2016.

Olivry, T., Saridomichelakis, M. Evidence-based guidelines for anti-allergic drug withdrawal times before allergen-specific intradermal and IgE serological tests in dogs. Veterinary Dermatology, 2013.

Loewenstein, C., Mueller, R.S. A review of allergen-specific immunotherapy in human and veterinary medicine. Veterinary Dermatology, 2009.

Olivry, T. et al. Treatment of canine atopic dermatitis: updated guidelines from the International Committee on Allergic Diseases of Animals. Veterinary Dermatology, 2015.

Related Reading

• Complete Guide to Dog Skin Allergies, Comprehensive overview of canine allergy types and all available management strategies.
• Dog Allergy Testing: What You Need to Know, A guide to intradermal and serum allergy testing, including what to expect and how results are used.
• Atopic Dermatitis vs. Food Allergy in Dogs, Why ruling out food allergy is critical before starting either Cytopoint or immunotherapy.
• How to Relieve Your Dog's Itchy Skin, Practical itch management tips that complement both Cytopoint and immunotherapy.

Emiel Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.